Columbia researchers have engineered bacteria as personalized cancer vaccines that activate the immune system to specifically seek out and destroy cancer cells.
Columbia researchers have used blockchain technology to build a system that can securely store, share, and analyze genetic and clinical data for precision medicine research.
A “loopy” discovery in bacteria is raising fundamental questions about the makeup of our own genome. And revealing a potential wellspring of material for new genetic therapies.
The latest advance in radiation therapy—using AI to adjust treatments as needed—is now available for select cancer patients at Columbia University Irving Medical Center/NewYork-Presbyterian.
Columbia University Irving Medical Center has been selected by the National Organization for Rare Disorders to join a national network aimed at improving patient care for people with rare diseases.
Columbia research finds that some cases of OCD are caused by damaging gene variants that, while rare, provide a needed starting point for the development of better therapeutics.
Adam Bass, MD, will join the Herbert Irving Comprehensive Cancer Center as founding director of the Center for Precision Cancer Medicine and director of gastrointestinal oncology.
Lowering testosterone may prevent the new coronavirus from entering lung cells and lessen COVID-19 severity, new Columbia University research suggests. A trial has now begun in three VA hospitals.
Based on the book by Columbia oncologist Siddhartha Mukherjee, the documentary also features Wendy Chung, David Goldstein, Samuel Sternberg, and Nancy Wexler. The two-part series airs April 7 and 14.
Columbia's Sandra Soo-Jin Lee leads a national study on the inclusion of ethnic minorities in genetic studies with a goal of enhancing precision medicine.